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FDA INDUSTRY GUIDANCE TARGETING
ANTIBIOTICS USED IN LIVESTOCK WILL NOT
RESULT IN JUDICIOUS USE OR REDUCTION
IN ANTIBIOTIC-RESISTANT BACTERIA
Sarah R. Haag*
This note evaluates the recent Food and Drug Administration
("FDA") efforts to promote judicious use1 of antibiotics in livestock,
assesses its potential for effectiveness, and recommends additional
steps that can be taken to combat antibiotic-resistant bacteria through
diminished antibiotic use in food-producing animals.
As a background, this note will first explain how the business of
farming relies on routine use of antibiotics in food-producing
animals. Second, it will look at the emergence of antibiotic-resistant
bacteria, associated health risks, and costs. Third, this note will
highlight various failed attempts over the last four decades to reduce
antibiotics used in food-producing animals. Fourth, it will examine
two recent FDA efforts to increase judicious use of antibiotics in
livestock with the stated goal of reducing antibiotic-resistant bacteria.
Last, this note will point out the incongruity in the FDA's stated
intent, and the probable consequences of the industry guidance.
In the conflict section, the note will weigh both sides of the
argument. Some believe recent FDA guidance is a necessary and
meaningful step toward reducing antibiotic usage and antibioticresistant bacteria. The note will then examine how this current
guidance and its language provide loopholes which critics believe
will result in the guidance being largely ineffective.
The analysis will propose a resolution to the conflict. Congress
should pass legislation to control antibiotic use. The FDA should
promulgate rules that would close loopholes left open by voluntary
suggestions and stop over the counter ("OTC") use of antibiotics for
*
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1. The FDA describes judicious use as avoiding unnecessary or inappropriate

use.
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subtherapeutic use immediately. Should animals fall ill, farmers
would be required to obtain prescriptions for antibiotics in medically
necessary cases. Surveillance mechanisms need to be put in place to
ensure compliance and if parties are found noncompliant, penalties
should result. The FDA should have authority to monitor and
enforce regulations and award fines for violations.
I.

BACKGROUND

This note will discuss antibiotic resistance at length. Antibiotic
resistance refers to bacteria that cause infections, which are resistant
to antibiotics. When bacteria become resistant to antibiotics, standard
treatments lose effectiveness. 2 As more and more bacteria develop
resistance to antibiotics, a public health issue emerges. The Food and
Drug Administration ("FDA") has recently engaged the public health
issue of antibiotic resistant bacteria. One of the FDA's3 areas of
concern is the widespread use of antibiotics with livestock.
To respond to the public health issue of antibiotic resistance and to
address the widespread use of antibiotics on farms, the FDA
publishes guidance letters directed at the pharmaceutical industry.
These letters are called Guidance for Industry. The first Guidance for
Industry addressing antibiotic resistance is #209, entitled "The
Judicious Use of Medically Important Antimicrobial Drugs in FoodProducing Animals" ("GFI 209") on April 13, 2012.

4

GFI 209

articulated the agency's current thinking regarding the judicious use
of medically important antimicrobial drugs in food-producing
animals.
GFI 209 considered recommendations of dozens of
scientific studies and reports produced over the past forty years. The
FDA recognized the health crisis associated with overuse of
antibiotics and called for judicious use.

2. World Health Organization Fact Sheet, http://www.who.int/mediacentre/

factsheets/fs 194/en!.
3. Antibiotics and Antibiotic Resistance, U.S. FOOD & DRUG ADMIN.,
http://www.fda.gov/drugs/resourcesforyou/consumers/buyingusingmedicinesafely/
antibioticsandantibioticresistance/default.htm.
4. All FDA Guidance for Industry, available at http://www.fda.gov/
AnimalVeterinary/GuidanceComplianceEnforcement/Guidanceforlndustry/ucm042

450.htm.
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Then, in December 11, 2013, the supporting Guidance #213 ("GFI
213") "New Animal Drugs and New Animal Drug Combination
Products Administered in or on Medicated Feed or Drinking Water of
Food-Producing Animals: Recommendations for Drug Sponsors for
Voluntarily Aligning Product Use Conditions with GFI #209" was
published. 5 GFI 213 tells drug sponsors they may voluntarily change
labels of antibiotics to comply with GFI 209 in the next three years.
A. Agribusiness Relies on Routine Use of Antibiotics
in Food-ProducingAnimals
Raising cattle today is a much different business than it was in
1953 when Don Tyson took a trip to the bank for Tyson Farms' first
loan.6 The family farm is nearly extinct today. In the past fifty
years, the United States has lost more than one million farms. 7
Instead, we have a lucrative industry of corporate meat producers.
Presently, there exists a four-firm concentration in meat productions. 8
Of the total U.S. market for poultry, pork, and beef, these four firms
control 51 percent, 65 percent and 85 percent respectively. 9 These
firms produce animals in concentrated animal feeding operations
("CAFOs"). 10 CAFOs produce millions of animals annually.
5. FOOD

&

DRUG ADMIN.,

GUIDANCE FOR INDUSTRY

#213,

available at

http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforceme
nt/Guidanceforlndustry/UCM299624.pdf [hereinafter GFI #213].
6. CHRISTOPHER LEONARD, THE MEAT RACKET 58 (2014) (I specifically
mention Tyson Farms, because it was founded in 1935 and Tyson Foods Inc. is the

largest meat producer in the world today).
7. Erin Williams, How Corporate Control Squeezes Out Small Farms, PEW
TRUSTS (July 18, 2012), http://www.pewenvironment.org/newsroom/fact-sheets/how-corporate-control-squeezes-out-small-farms-8589942044.
8. Roberto A. Ferdman, Americans Have Never had So Few Options in
Deciding What
Company
Makes
Their Meat,
June
11,
2014,
CHARITABLE

http://www.washingtonpost.comlblogslwonkbloglwp/2014/06]]1/americans-havenever-had-so-few-options-in-deciding-what-company-makes-their-meat/(The four

companies are Tyson Foods, JBS, Cargill, and Smithfield Foods. Another
unrelated issue arising from a four firm concentration is the power to manipulate
prices; in this case, of meat).
9. Williams, supra note 7.
10. Region 7 Concentrated Animal Feeding Operations (CAFOs), What is a
CAFO?, U.S. ENVTL. PROTECTION AGENCY, http://www.epa.gov/region7/water/
cafo/. (Describing CAFOs as a type of Animal Feeding Operation (AFO) where
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America has one of the highest meat consumption rates in the
world.11
1. CAFOs Create Deplorable Conditions for Livestock
Livestock raised on CAFOs do not typically have a lot of space to
roam. A CAFO confines animals for more than 45 days of a growing
season in an area that does not produce vegetation and meets certain
size thresholds. 12 Pigs and chickens often live shoulder to shoulder
and often do not see the light of day. Cows live confined in pens and
stand in feet of their own feces. The close quarters in which animals
are raised increases the animals' stress levels 13 and creates an everpresent risk of disease.14 CAFOs also produce so much animal waste
that the Environmental Protection Agency ("EPA") has categorized it
as a pollutant.1 5 There is little legal protection controlling animal
welfare.
Many statutes exempt acceptable animal husbandry
practices or exclude farm animals from their purview. 16 Animal
husbandry practices are set by the industry and profits are the guiding
factor.1 7 While the manner in which animals are raised can and
should be changed, animal welfare is beyond the scope of this note.
Instead, this note will focus on the role antibiotics play on the
industrial farm.

animals are confined for at least 45 days of a 12-month period. "AFOs congregate
animals, feed, manure and urine, dead animals, and production operations on a
small land area.")
11. Eliza Barclay, A Nation of Meat Eaters: See How It All Adds Up, NAT'L
PUB. RADIO BLOG

(June 27, 2012, 3:03 AM), http://www.npr.org/blogs/thesalt

/2012/06/27/155527365/visualizing-a-nation-of-meat-eaters.
12. Robyn Mallon, The Deplorable Standard of Living Faced by Farmed
Animals in America's Meat Industry and How to Improve Conditions by
Eliminating the CorporateFarm, 9 MICH. ST. J. MED. & L. 389, 395 (2005).

13. Id. at 398-99.
14. Barbara O'Brian, Animal Welfare Reform and the Magic Bullet: The Use
and Abuse of Subtherapeutic Doses of Antibiotics in Livestock, 67 U. COLO. L.

REv. 407, 412 (1996).
15. Scott Jerger, EPA's New CAFO Land Application Requirements: An
Exercise in UnsupervisedSelfMonitoring, 23 STAN. ENVTL. L. J. 91, 99 (2004).
16. See O'Brian, supra note 14, at 408.
17. See id.
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2. Antibiotics are Routinely Used to Promote Growth,
Prevent Illness, and Treat Disease
Growing food is no longer referred to as farming or ranching.
Instead, we now call the business of growing food "agribusiness."'1 8
Drugs are now used to make animals gain weight faster - known in
the industry as "production, ' ' 19 and the animals that we eat are now
described as "food-producers. 2 ° Minimally funded federal agencies
like the FDA, charged with guarding public health, are no match for
wealthy pharmaceutical giants concerned mainly with shareholder
profits.
The United States has a rich history of cases where the market
takes an early lead with a new product as they scoop up unregulated
profits. 21 From cigarettes to asbestos, formaldehyde, and
dichlorodiphenyltrichloroethane ("DDT"), each were sold and used
in copious amounts. 22 The public believed products were safe for use
as advertised, and companies were quick to assure its consumers
these products were free from unreasonable risks. 23 Public health
again fails to garner appropriate attention in the marketplace despite
study after study warning us of the risks. Meanwhile, legislative and
judicial branches exhaust the weapons in their respective arsenals to
combat antibiotic overuse.
The government is often slow to recognize and protect against
dangers lurking in FDA-regulated products. Valerie Watnick, author
of multiple articles on food quality and pesticide regulation, devoted
an entire article to the FDA's reluctance to step in where there is a
disconnect between the public's understanding of the dangerousness
of pesticides and agency responsibility to protect public health.24
18. See Mirriam-Webster Dictionary, agribusiness is defined as the business of
industry of farming or agriculture: farming through of as a large business.
19.

GUIDANCE FOR INDUSTRY

#209, U.S.

FOOD

&

DRUG ADMIN.,

available at

http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforceme
nt/Guidanceforlndustry/UCM216936.pdf [hereinafter GFI #209].
20. Id.
21. Valerie Watnick, Pesticides and Children: Unwitting Participants in
Experimentation, 13 CARDOZO J.L. & GENDER 801, 804 (2008).
22. Id. at 804
23. Id.at 804
24. See id.
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For these reasons, it often takes an outsider to point out a system is
not working. The Federal Meat Inspection Act was enacted partially
in response to Upton Sinclair's novel, The Jungle.2 5 Currently, there
is an information disconnect between the industrial farm setting and
how diners believe their meat reaches the dinner plate.
Environmental advocacy groups like Natural Resources Defense
Council ("NRDC"), advocate for greater transparency regarding what
drugs are in the meat that consumers are buying at the supermarket.26
Current conditions and practices on CAFOs are not well known
thanks to "Ag-gag laws," as they are colloquially called. These laws
hide the reality of factory farming by making it a crime to report
animal abuse. Eight states (Montana, North Dakota, Iowa, Missouri,
Arkansas, Kansas, Utah, and South Carolina) have passed ag-gag
provisions.
In some of these states, taking photos or videos of
farms is a felony that is deemed a terrorist activity and places the
offender on a "terrorist registry. ' ' 2 8 Without First Amendment rights
to confront agricultural practices, reporters cannot gather information
to report on the food industry, 29 and the public is effectively kept in
the dark regarding the origin of their meat.
The FDA promulgates regulations regarding antibiotic use in
livestock. A national program called Beef Quality Assurance offers
guidelines to the beef industry for cattle production. 30 As seen from
their guidelines on Feed Additive and Medications, 3 1 they advise the
beef industry to follow only FDA regulation and not to exercise

25. See Richard A. Merrill, The Centennial of U.S. Food Safety Law: A Legal
and Administrative History, in TOWARD SAFER FOOD 23 (Sandra A. Hoffman &
Michael R. Taylor eds., 2005).
26. To FightSuperbug Crisis, PublicNeeds More Data on Farm Animal Drugs,
NAT. RES.

DEFENSE COUNCIL

(Mar. 20, 2013), http://www.nrdc.org/media/

2013/130320.asp.

27. Ted Genoways, Gagged by Big Ag,
available at

MOTHER JONES,

July/Aug. 2013,

http://www.motherjones.com/environment/2013/06/ag-gag-laws-

mowmar-farms.
28. Id. at4.
29. Kristen Rasmussen, Efforts to Restrict Recordings of Animal Abuse Could
Impede Newsgathering, 36 THE NEWS MEDIA AND THE LAW 4, 4 (2012).
30. See generally BEEF QUALITY ASSURANCE, http://www.bqa.org/.
31. Feed Additives and Medications, BEEF QUALITY ASSURANCE,
http://www.bqa.org/feedadditives.aspx.
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discretion to reduce use of antibiotics, so beef producers must adhere
to FDA regulations regarding antibiotic use.
B. Emergence of Antibiotic-ResistantBacteria,
Associated Health Risks, and Related Costs

Antibiotics are sold to farmers and ranchers not only to treat
disease, but also to prevent animals from getting sick (preventative
uses) and to increase the rate of weight gain or improve feed
efficiency (production purposes). 32 According to former FDA
commissioner, David A. Kessler, 80 percent of the thirty million
pounds of antibiotics sold in 2011 went to livestock.33 As these
antibiotics are being sold to meat suppliers, the dangers associated
with sub-therapeutic uses of antibiotics are closely examined by the
scientific community at home34 and abroad.35

32. See generally GFI #209 and GFI#213.
33. David A. Kessler, Antibiotics and the Meat We Eat, N.Y. TIMES, March 28,

2013, at A27.
34. See, e.g., COMM. ON THE SCIENTIFIC BASIS OF THE NATION'S MEAT AND
POULTRY INSPECTION PROGRAM, FOOD & NUTRITION BD. COMM'N ON LIFE SCI.
NAT'L RESEARCH COUNCIL, MEAT AND POULTRY INSPECTION: THE SCIENTIFIC

(Nat'l Acad. Press, 1985) (explaining the
inspection process for the safety of meat and poultry products for human
BASIS OF THE NATION'S PROGRAM,

consumption); Stuart B. Levy, Playing Antibiotic Pool: Time to Tally the Score,

311 N.

ENGL. J. MED. 663-65 (1984); K.A. MEISTER & R. A. GREENBERG, AM.
COUNCIL ON SCI. & HEALTH, ANTIBIOTICS IN ANIMAL FEEDS: A THREAT TO
HUMAN HEALTH (1983) (The development of antibiotic-resistant bacteria resulting

from feed additives and the transfer of resistant bacteria to humans are matters of
public health concern.); Marc Linder, I Gave My Employer a Chicken That HadNo
Bone: Joint Firm - State Responsibility for Line - Speed-Related Occupational
Injuries, 46 CASE W. RES. L. REV. 33, 41-42 (1995) (Unintended consequences of

the sub-therapeutic doses of antibiotics added to chicken feed is resulting in
bacteria that have become resistant to antibiotics, such as salmonella, E. coli, and
campylobacter jejuni. These antibiotic resistant bacteria cause thousands of cases
of diarrheal disease and deaths annually.).
35. EUROPEAN

COMM'N.,

Ban on Antibiotics as Growth Promoters in Animal

FeedEnters into Effect (Dec. 12, 2005), http://europa.eu/rapid/press-release IP-051687_en.htm (In January 2006, the European Union banned the use of antibiotics
as growth-promoters in feed and do not allow antibiotics to be used for non-

medical purposes).
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Further, the use of such antibiotics unsurprisingly resulted in the
emergence of antibiotic-resistant pathogenic bacteria.36
All animals normally have bacteria in and on their bodies.
When an animal is treated with a drug, all the bacteria in
and on that animal are also exposed to the drug. Some of
the exposed bacteria may become resistant, meaning that
the drug, and possibly37 similar drugs, will no longer work
against those bacteria.
Each year in the United States, at least 2 million people
become infected with bacteria that are resistant to
antibiotics and at least 23,000 people die each year as a
direct result of these infections. Many more people die
from other conditions that
were complicated by an
38
antibiotic-resistant infection.
There are huge health costs associated with multi-drug resistant
("MDR") bacteria that won't react to antibiotics. Treating antibiotic
resistant infections costs between $16.6 and $26 billion annually.3 9
Emergence of the Superbug, or antibiotic-resistant bacteria, is a
health crisis of global proportions recognized and monitored by the
Food and Agriculture Organization of the United Nations and the

36. Robert Dorit, Routes of Resistance, 97 AMERICAN SCIENTIST 20, 20 (2009),
available at
http://www.americanscientist.org/issues/pub/routes-of-resistance.
Dorit is a biology professor at Smith College who studies molecular evolution specifically evolving antimicrobials that reduce antibiotic resistance.

37. ANIMAL HEALTH LITERACY, FROM AN IDEA TO THE MARKETPLACE: THE
JOURNEY OF AN ANIMAL DRUG THROUGH THE APPROVAL PROCESS 5 (U.S. Food &
Drug Admin., 2013), available at http://www.fda.gov/AnimalVeterinary/
ResourcesforYou/AnimalHealthLiteracy/ucm219207.htm.
38.

CENTER FOR DISEASE CONTROL, ANTIBIOTIC RESISTANCE THREATS IN THE

STATES (U.S. Dept. of Health & Human Serv., 2013), available at
http://www.cdc.gov/drugresistance/threat-report-2013/index.html.
UNITED

39. ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS ("APUA"), ANTIBIOTICRESISTANT INFECTIONS COST THE U.S. HEALTHCARE SYSTEM IN EXCESS OF $20
BILLION ANNUALLY (Biomdrieux, 2009) available at http://www.tufts.edu/
med/apua/news/aam report.pdf.
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World Health Organization. 40 However, antibiotics continue to be
used in tremendous quantities in spite of evidence that their overuse
is compromising human health. 41 Nothing seems to be able to stop
the antibiotic use - not international warnings, not congressional
action, not citizen petitions, not shareholder letters, and certainly not
action by the one42agency tasked with the mission of protecting public
health, the FDA.
C. FailedAttempts to Reduce Use ofAntibiotics
in Food-ProducingAnimals

1. Regulatory - Balkanized State of Federal Food Safety
The responsibility to protect food safety falls on the shoulders of
four different agencies, the United States Department of Agriculture
("USDA"), EPA, CDC, and FDA. In a regulatory system that is
constantly shifting, reorganizing, and reassigning duties, it is no
surprise that each agency is responsible for different segments of the
same issue - chemicals, pesticides, or drugs.
The USDA's Food Safety and Inspection Service ("FSIS")
regulates meat through continuous inspection of processing
operations and review of product labels.43 The USDA enforces EPA
pesticide tolerances in meat. The USDA, therefore, has little power
to control antibiotics in meat other than to ensure the proper labeling
of meat that is has been treated with antibiotics and meat that is not
treated with antibiotics.
The EPA controls the Office of Pesticide Programs ("OPP"),
which registers pesticides and sets the pesticide tolerances that are
40. Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment

("JEMRA"),
CODEX
ALIMENTARIUS
INT'L
FOOD
STANDARDS,
http://www.codexalimentarius.org/scientific-basis-for-codex/j emra/en.
41. Ron Gasbarro, Combating Growing Antibiotic Resistance, AMERICAN

Feb. 1996, at 49 (There is a possible rise in cases of diseases that have
nearly been eradicated such as: tuberculosis, malaria, and dysentery possibly due to
antibiotic overuse).
42. See, e.g., What We Do, U.S. FOOD & DRUG ADMIN. (Aug. 5, 2014),
http://www.fda.gov/aboutfda/whatwedo/ ("FDA is responsible for protecting the
public health by assuring the safety, efficacy and security of... our nation's food
DRUGGIST,

supply .. ").
43. 21U.S.C. §§ 451 -471,601 - 695 (2012).
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enforced by the FDA or FSIS.4 4 It is outside the EPA's mission to
monitor antibiotic use.
The Centers for Disease Control and Prevention ("CDC"), is a
federal agency under the Department of Health and Human Services
("HHS"). The CDC serves as the primary clearinghouse for disease
surveillance data, and the chief resource for epidemiological
investigations. 45
In exercising its role in epidemiological
investigations, the CDC could potentially help monitor the health
problems resulting from long-term exposure46of the human population
to meat with residual toxicity of antibiotics.
In 2013, the CDC released a comprehensive report entitled,
"Antibiotic Resistance Threats in the United States." 47 In that report,
the CDC calls for a multifaceted approach and partnerships between
federal, state, and local agencies and departments to prevent
antibiotic-resistant foodborne infections - some with animal
reservoirs and others human reservoirs. 48 The report highlights the
link between antibiotic uses in food-producing animals and
emphasizes the importance of limiting use to medically necessary as
opposed to sub-therapeutic uses. 49

The FDA is responsible for the safety of foods including labels and
additives, human prescription and over the counter drugs, and
veterinary products - including feeds and drugs. 50 The FDA also
regulates veterinary drugs. 51 The FDA also looks at health risks
posed by foodborne chemicals and microbiological contaminants. 52
The Center for Veterinary Medicine ("CVM") within the FDA is

44. 7 U.S.C. §§ 135 - 136y (2012); 21 U.S.C. § 342 (a)(2)(B) (2012).
45. National Notifiable Diseases Surveillance System

("NNDSS'), CDC,

wwwn.cdc.gov/nndss/ (NNDSS home page outlines the surveillance system
involving collection, analysis, and sharing infectious diseases).
46. TOWARD SAFER FOOD, supra note 25, at 29.
47. See Antibiotic Resistance Threats, supra note 36.
48. Id. at 36.
49. Id. at 37.
50. What Does FDA Regulate?, U.S. FOOD & DRUG ADMIN. (Jun. 12, 2014),
http://www.fda.gov/aboutfda/transparency/basics/ucml94879.htm.
51. 21 U.S.C. § 393 (b)(2)(2012).
52. Risk & Safety Assessment, U.S. FOOD & DRUG ADMIN.,
www.fda.gov/Food/FoodScienceResearch/RiskSafetyAssessment/ (Risk & Safety
Assessment web page reflects the FDA's mission of preventing contamination and
illness via risk analysis of chemical and microbiological contaminants).
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responsible for premarket approval of New Animal Drug
I
I
1
153
Applications ("NADA") and surveillance of animal drug use.
The FDA is concerned with threats of acute poisoning caused by
harmful microorganisms and controlling toxic materials that enter
food by human activity.54 The FDA's Center for Food Safety and
Applied Nutrition ("CFSAN") monitors the safety and labeling of
most non-meat and processed foods, and licenses food-use chemicals
other than pesticides.55 Many scholars and food safety advocates call
on the FDA to make critical changes that would answer this problem.
The FDA is responsible for enforcing the Food, Drug, and
Cosmetic Act ("FDCA"). Section 401(a)(2)(C)(ii) of the FDCA
defines adulterated food as one that bears or contains a new animal
drug that is unsafe within the meaning of FDCA Section 512.56 New
animal drugs are deemed unsafe under Section 512 unless they are
the subject of an approved New Animal Drug Application
("NADA"), and the substance, use, and labeling conform to the
approved NADA.57 Section 402 tells us that food is adulterated if it
contains poisonous or deleterious substances that render it injurious
to health. The caveat, however, is in its next clause, which provides
an exception that excludes those substances if the quantity added
would not ordinarily be injurious to health.58
Aware of these antibiotic-resistant bacteria, or "multi-drug
resistant superbugs," as they are now called, 59 the government
established National Antimicrobial Resistance Monitoring System for
Enteric Bacteria ("NARMS") in 1996. 6o
NARMS required
collaboration between state and local public health departments, the
53. NATIONAL RESEARCH COUNCIL, ANIMAL HEALTH AT THE CROSSROADS:
PREVENTING, DETECTING, AND DIAGNOSING

244 (The Nat'l Academies Press,

2005).
54. TOWARD SAFER FOOD, supra note 25, at 31.

55. 21 U.S.C. §§301 - 397 (2012).
56. Martin J. Hahn, FDA Has the Legal Authority to Adopt a Threshold of
Toxicological Concern (TTC) for Substances in Food at Trace Levels, 65 FOOD
DRUG L.J. 217, 222 (2010).
57. Id.
58. See Hahn, supra note 56, at 217, 219.
59. Zosi Kmietowicz, Superbugs are Beating at the Gates, NEW SCIENTIST, July
17, 1999, http://www.newscientist.com/ns/19990717/newsstoryl 2.html.
60. See National Antimicrobial Resistance Monitoring System for Enteric
Bacteria, CENTER FOR DISEASE CONTROL, http://www.cdc.gov/narms/.
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CDC, the FDA, and the USDA. 61 The purpose of NARMS was to
track antimicrobial susceptibility of intestinal bacteria in people
(CDC), retail meats (FDA), and food animals (USDA). 6 2
Every year, respective NARMS committees publish Human
Isolates, Retail Meat Isolates, and Animal Isolates Reports.63 In
2011, the FDA NARMS Retail Meat Annual Report found antibioticresistant bacteria on 81 percent of ground turkey, 69 percent of pork
chops, 55 percent of ground beef, and 39 percent of chicken breasts,
wings, and thighs. 64 For all of the compilation and tracking of data,
65
NARMS fails to collect data on the sources of contaminated meat,
66
and NARMS committees only meet once a year.
It is surprising
that with such high rates of antibiotic-resistant bacteria present in
retail meat, NARMS does not meet more frequently. Stuart Levy,
President of the Alliance for Prudent Use of Antibiotics, Professor at
Tufts University School of Medicine, points out that while drug
residue is being monitored, retail meat still has a high contamination
of organisms. 67 These organisms are not followed,
and the drug
68
amounts.
undetectable
small
might be present in

61. See id.
62. See id.
63. See NARMS
CONTROL

&

ANNUAL HUMAN ISOLATES REPORTS, CENTER FOR DISEASE

PREVENTION,

available at

http://www.cdc.gov/narms/reports/

index.html (last visited Nov. 21, 2014); NARMS

RETAIL MEAT ANNUAL REPORTS,

U.S. FOOD & DRUG ADMIN., available at http://www.fda.gov/AnimalVeterinary/
SafetyHealth!AntimicrobialResistance/NationalAntimicrobialResistanceMonitoring
System/ucm059103.htm (last visited Nov. 21, 2014); NARMS ANIMAL ISOLATES
COMPREHENSIVE ANNUAL REPORTs, U.S. DEPT. OF AGRIC., available at
http://ars.usda.gov/Main/docs.htm?docid-6750&page-4 (last visited Nov. 21,
2014).
64. U.S. FOOD & DRUG ADMIN.,

NARMS RETAIL MEAT ANNUAL REPORT

(2011),
available
at
http://www.fda.gov/AnimalVeterinary/SafetyHealth!
AntimicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/ucm3
34828.htm.
65. See Maryn McKenna, Drug-ResistantBacteria on Chicken: It's Everywhere
and the Government Can't Help, WIRED MAGAZINE, Dec. 19, 2013,
http://www.wired.com/2013/12/chicken-cr-pew/.
66. See, e.g., NARMS MEETINGS LIST, U.S. FOOD & DRUG ADMIN.,
http://www.fda.gov/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/Natio
nalAntimicrobialResistanceMonitoringSystem/ucm059135 .htm.
67. Video: Farm Animals and Antibiotics: Highlight from Battling DrugResistant Superbugs: Can We Win?, (The Forum at Harvard School of Public
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21 CFR § 5 10.110 is entitled "Antibiotics Used in Food-Producing
Animals." It recognizes the concern around the extensive use of
antibiotics with food-producing animals and looks at antibiotic
69
residue found in the edible tissue, milk, or eggs of treated animals.
With the focus on reduction of antibiotic residue, attention is drawn
away from the core issue of use on the farm and resulting MDR
resistant bacteria.
2. Civil - Citizen Petitions and Shareholder Letters Failed
70

71

The FDA denied citizen petitions in 1999 and 2005.
In 2012,
NRDC plaintiffs filed complaints alleging that FDA denials of these
petitions amounted to Administrative Procedure Act ("APA") and
FDCA violations. 72 In the midst of these failed citizen petitions,
President Clinton signed the Animal Drug Availability Act 1996
("ADAA"). 73 The law was designed to increase the number of
animal drugs on the market by relaxing requirements for
effectiveness studies and eliminating the requirement for field
studies. ADAA allows for flexible labeling for a range of doses
rather than an optimum dose.74

Health presented Feb.
watch?v-131 Bg-lqZM.
68. Id.

5,

2014),

available at

http://www.youtube.com/

69. 21 C.F.R. § 510.110 (2014).
70. The 1999 Petition was to rescind approvals of subtherapeutic uses in
livestock or antibiotics use in (or related to those used in human medicine) and is
available
at http://www.ucsusa.org/sites/default/files/legacy/assets/documents/
food and agriculture/1 999-FDA-Petition.pdf.
71. In 2005 another petition was filed. This time, seeking withdrawal of
approvals of certain herdwide/flockwide uses of critically and highly important
antibiotics pursuant to guidance #152. The petition is available at
http://www.ucsusa.org/sites/default/files/legacy/assets/documents/food-and-agricu
lture/2005-FDA-Petition.pdf.
72. Natural Res. Def. Council, Inc., v. U.S. Food & Drug Admin., 884 F. Supp.
2d 127, 130 (S.D.N.Y. 2012).

73. Animal Drug Availability Act of 1996, Pub. L. No. 104-250, 110 Stat. 3151
(codified in scattered sections of 21 §U.S.C. (2012)).
74. See U.S. FOOD & DRUG ADMIN., ANIMAL DRUG AVAILABILITY ACT OF
1996
GUIDANCE,
available
at
http ://www. fda.gov/AnimalVeterinary/
GuidanceComplianceEnforcement/ActsRulesRegulations/ucml 05940.htm.
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Another tactic by which change may be sought in a corporate
setting is via the shareholder relationship with a company. In 2009,
disgruntled shareholders, Adrian Dominican Sisters and Trinity
Health, attempted to correct antibiotic overuse by directly petitioning
Tyson Foods, Inc. via a proposal letter. Giant pork producer Tyson
Foods, Inc., was petitioned by shareholders to cease sub-therapeutic
use of antibiotics in hog production, but Tyson's legal team ducked
any accountability by claiming this request dealt with matters related
to Tyson's business operations and were ordinary practice. Records
of the letters between shareholders and Tyson's 7legal
representatives
5
can be viewed by the public on the SEC website.
The case Animal Legal Def. Fund, Inc. v. Provimi Veal Corp.
discusses warnings or labeling of veal calves raised with growth
hormones.76 The Animal Legal Defense Fund ("ALDF") of Boston
sued Provimi Veal Corp. claiming their right to know about the
company's animal husbandry practices and drugs used in their meat
production. 77 The court held that the complex federal regulatory
scheme monitoring industry marketing, labeling, and packaging of
meat preempted plaintiffs' claims. 78 The court further explained that
the FDCA does not grant private rights of action. 79 The First Circuit
reaffirmed this decision on appeal.
With a complex regulatory
scheme that preempts private rights of action, seeking accountability
via the judiciary is problematic.
3. Legislative - Congressional Actions Failed
Legislative measures to reform these practices have also failed in
each of the last three Congressional sessions. Bills to preserve
antibiotics for medical treatment were introduced in the 110th (H.R.
75. See Letter from Adrian Dominican Sisters to Tyson Foods (Aug. 31, 2009)
(on file with the Sec. & Exch. Comm'n), available at http://www.sec.gov/
divisions/corpfinlcf-noaction! 14a-8/2009/adriandominicansisters 112509-14a8.pdf.
76. Animal Legal Defense Fund-Boston, Inc. v. Provimi Veal Corp., 626 F.
Supp. 278, 283 (D. Mass. 1986).
77. Id.
78. Barbara O'Brien, Animal Welfare Reform and the Magic Bullet, 67 U.
COLO. L. REV. 407, 436. (1996).
79. Provimi, 626 F. Supp. at 283.
80. Animal Legal Defense Fund-Boston, Inc. v. Provimi Veal Corp., No. 861234, 1986 U.S. App. LEXIS 32019, at *1 (1st Cir. Aug. 12, 1986).
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962), 111 th (H.R. 1549), and 112th (H.R. 965) Congresses. 81 The
Bill's full title is "To amend the FDCA to preserve the effectiveness
of medically important antibiotics in the treatment of human and
animal disease.''82 Not one of the bills advanced to the floor.
Rep. Louise Slaughter (D-NY) introduced the most recent bill,
H.R. 965 on March 9, 2011, and it was referred to the Committee on
Energy and Commerce on June 15, 2011.
The bill died in
83
committee.
Ms. Slaughter, a public-health microbiologist and longtime
champion of protecting antibiotics for critical medical uses, released
the following statement after the bill failed to advance.
How many more news reports, outbreaks or deaths must
there be before we really crack down on the source of the
antibiotic-resistance crisis: the overuse of antibiotics on the
farm? [... ] These studies draw a troubling conclusion: that
the presence of antibiotic-resistant bacteria in meat is more
widespread than we thought, and our federal regulatory
agencies simply refuse to hold the industry accountable.
The failure of our regulatory structure to protect public
health is completely unacceptable. 84
In March 2013, the Senate Health, Education, Labor, and Pensions
("HELP") Committee failed to add new reporting requirements
related to the use of antibiotics on livestock used for human food
production. 85 Senators Diane Feinstein (CA) and Kristen Gillibrand
(NY) offered a provision that would have required the FDA to
disclose additional information about the marketing and sale of
antibiotics, whether the sales were over the counter or prescription."
Pharma and livestock lobbyists successfully swayed the Committee
to avoid discussion or consideration of the amendment. The
81. Preservation of Antibiotics for Medical Treatment Act of 2009, H.R. 1549,
11 1th Cong. (2009).
82. Id.

83. Preservation of Antibiotics for Medical Treatment Act of 2011, H.R. 965,
112th Cong. (2011).
84. McKenna, supra note 65.
85. See Kessler, supra note 33.
86. See id.
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availability of antibiotics via OTC or prescription potentially impacts
the use of the drug. OTC approval means farmers can obtain the
drug more easily than by prescription and may administer in any
quantity without veterinary oversight.
4.

Judiciary - Judge Katz's 2012 Order for FDA to Initiate
Withdrawal of Antibiotic Approval

There was a recent victory in the court system regarding FDA
withdrawal of antibiotic approval. In 2011, the NRDC brought suit
against the FDA for its failure to follow through on the dormant
NOOH from 1977 to withdraw approval for sub-therapeutic use of
penicillin and tetracyclines. 87 It further alleged that FDA failure to
withdraw approval was in violation of the APA, 5 U.S.C. § 706(1).88
In 2012, Magistrate Judge Theodore Katz, S.D.N.Y. handed down
a decision reversing agency inaction. Judge Katz granted summary
judgment for NRDC with the following:
Defendants are hereby ordered to initiate withdrawal
proceedings
for
the
relevant
NADAs/ANADAs.
Specifically, the Commissioner of the FDA or the Director
of the CVM must re-issue a notice of the proposed
withdrawals (which may be updated) and provide an
opportunity for a hearing to the relevant drug sponsors; if
drug sponsors timely request hearings and raise a genuine
and substantial issue of fact, the FDA must hold a public
evidentiary hearing. If, at the hearing, the drug sponsors
fail to show that the use of the drugs is safe, the
Commissioner must issue a withdrawal order. 89
Judge Katz concluded the FDA must initiate withdrawal
proceedings for antibiotics called out in citizen petitions because
reasons for not doing so were arbitrary and capricious. 9°

87. See NaturalRes. Def Council, Inc., 884 F. Supp. 2d at 137.
88. Id. at 130.

89. Id. at 151.
90. Natural Res. Def Council, Inc., v. U.S. Food & Drug Admin., 872 F. Supp.
2d 318, 342 (S.D.N.Y. 2012).
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In response to the order, the FDA said it believed it was legally
obligated to conduct formal process with full notice and hearing
period before it could initiate withdrawal approvals. 91
5. International Perspective
In many areas of the law, it is helpful to gain an international
perspective. Perhaps the issue is largely unsettled or international
actors are facing similar dissention. When compared to the United
States decades-long reluctance to address antibiotic use, other
countries have already taken action. Europe took a number of steps
to limit antibiotic use and to combat antibiotic-resistant bacteria.92
Laws restricting additives in animal feed were enacted in 1970.
Sweden began phasing out antimicrobial growth promoters in foodproducing animals in 1986. 93 In January 2006, the European Union
("EU") banned the use of antibiotics both for non-medical purposes
and as growth promoters in feed. 94 Ceasing non-therapeutic use of
antibiotics yields fast results in combating antibiotic resistance.
Denmark instituted a voluntary ban in 1998 and followed with a full
ban in 2000. 95 Under the new law, all uses of antibiotics must be
prescribed by a veterinarian in a valid veterinarian-client-patient
relationship; veterinarians must report all sales of antibiotics and
must not profit from their sale.96 The ban has reduced human health

91. See Lisa Heinzerling, Undue Process at the FDA: Antibiotics, Animal Feed,
and Agency Intransigence,37 VT. L. REV. 1007, 1008 (2013).
92. See, e.g., Council Directive 70/524, 1970 J.O. (L 270) 1-17 (EC); Council

Regulation 1831/2003, On Additives for Use in Animal Nutrition, 2003 O.J. (L
268) 29-43 (EC).
93. See Carol Cogliani, Restricting Antimicrobial Use in Food Animals:
Lessonsfrom Europe, 6 MICROBE 274 (2011).
94. See Press Release: Ban on Antibiotics as Growth Promoters in Animal Feed
Enters into Effect, EUROPEAN COMMISSION (Dec. 22, 2005), http://europa.eu/rapid/

press-release IP-05-1687 en.htm.
95. See Issue Brief.Avoiding Antibiotic Resistance: Denmark's Ban on Growth
PromotingAntibiotics in Food Animals, THE PEW CHARITABLE TRUSTS (Nov. 1,

2010), http://www.pewhealth.org/reports-analysis/issue-briefs/avoiding-antibioticresistance-denmarks-ban-on-growth-promoting-antibiotics-in-food-animals85899371053.
96. See id.
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risk, increased livestock and poultry production,
and has cut
97
meats.
in
and
farms
on
resistance
antibiotic
Frank Aarestrup, D.V.M., Ph.D., and head of the EU Reference
Laboratory for Antimicrobial Resistance, authored a 2012 article on
Denmark's antibiotic ban stating, "instead of eviscerating the
nation's pork industry, those moves contributed to a 50 percent rise
in pork production." 98 Denmark took a three-pronged approach to
halt use of antibiotics for growth promotion.99 First, it enacted laws
banning improper use; second, it implemented a robust surveillance
and enforcement system; and third, it barred veterinarians from
antibiotic sales profits, thereby eliminating an incentive to
overprescribe. 100 Aarestrup goes on to encourage wary American
counterparts by saying, "Farmers and their livestock can thrive
without the heavy use of antibiotics... With a little effort, I believe
that other
countries can and must help their farmers to do the
10 1
same."
D. The FDA has not Withdrawn Approvals for
Sub-Therapeutic Use ofAntibiotics in Livestock

According to Mark Bittman, the FDA works with a shoestring
budget (US $3-4 billion FY 2011 and 2012),102 while the largest four
meat companies' sales total nearly US$100 billion.103 There is ample

97. Id.
98. Frank Aarestrup, Get Pigs off Antibiotics, 486
2012).

NATURE 465, 465 (June 28,

99. Id. at 466.

100. Id.
101. Id.

102. U.S. FOOD & DRUG ADMIN., FY 2013 BUDGET OVERVIEW, available at
http://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/Budget
Reports/UCM301719.pdf (last updated May 21, 2012).
103. See Monica Watrous, Ranking the Meat and Poultry Industry's Top 10
Companies,
FOOD
BUSINESS
NEWS,
Mar.
19,
2013,

http://www.foodbusinessnews.net/articles/news-home/BusinessNews/2013/03/Ra
nking the meat andpoultryi.aspx?ID = {E1E627B9-E4CE-40A0-A3E0ED9B597FCBFE}

(Tyson US$33.3 billion, JBS US$31.3 billion, Cargill US$18

billion, and Smithfield US$13.09 billion in sales).
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financing
available
to fund
SuperPACs
0 and agribusiness
($153 million
in 2013)105
who
bend congressional
ears. 10 6 lobbyists

1. 1977 - 2011 Notice of Opportunity for Hearing
Antibiotics came to be approved for purposes other than treating
active infections because Congress granted the FDA authority to
waive safety and efficacy requirements if it found doing so would be
safe. 10 7 Farmers quickly discovered antibiotics helped animals gain
weight faster, and the FDA approved its use in 1951.10 8 Two years
later, antibiotic use to prevent infection was approved. 10 9 "Shortly
after the licensing and use in livestock of fluoroquinolone, a powerful
new class of antimicrobials, fluoroquinolone-resistant Salmonella
and Campylobacter isolations from animals, and humans
increased." 1 10
By the 1960's, the FDA became worried about the effects of subtherapeutic antibiotic use so the FDA formed a Task Force to study
it. The Task Force published a report in 1972 linking sub-therapeutic
use of antibiotics in livestock and increased antibiotic-resistant
bacteria in livestock and meat intended for human consumption."'
Aware of risk of antibiotic resistance in humans, the FDA published
a rule in the Code of Federal Regulations in 1973 asking drug
companies to present evidence that sub-therapeutic use of antibiotics
104. McCutcheon v. Federal Election Commission, 2013 WL 2102847 (U.S.
May 13, 2013).
105. Graph, Annual Lobbying on Agribusiness, OPENSECRETS.ORG,
https://www.opensecrets.org/lobby/indus.php?id-A&year-2013 (last visited Nov.
7,2014).
106. Mark Bittman, Bacteria 1, F.D.A. 0, N.Y. TIMES OPINIONATOR (Dec. 27,
2011, 9:00 PM), http://opinionator.blogs.nytimes.com/2011/12/27/bacteria-1-f-d-a-

0/.
107. Fed. Food, Drug, and Cosmetic Act of June 25, 1938, ch. 281, sec. 507, § 3,
59 Stat. 463 (1945) (repealed 1997).
108. Miscellaneous Amendments to Part 146, 21 C.F.R. § 146.61 (2014).
109. Exemption from Certification of Antibiotic Drugs for Use in Animal Feed,
18 Fed. Reg. 2335, 2335-36 (Apr. 22, 1953) (codified at 21 C.F.R. § 146.62).
110. See Use of Antimicrobials Outside Human Medicine and Resultant
Antimicrobial Resistance in Humans: Fact Sheet No. 268, WORLD HEALTH ORG.
(2002), availableat http://whqlibdoc.who.int/fact sheet/2002/FS 268.pdf.
111. Natural Res. Def. Council, Inc., v.U.S. Food & Drug Admin., 760 F.3d
151, 154 (2d Cir. 2014).

332

FORDHAM ENVIRONMENTAL LA W RE VIE W

[VOL. XXVI

did not violate FDCA. 112 And in 1977, the Director of BVM
announced a notice of opportunity for a hearing under 21 U.S.C. §
360(b)(e)(1) regarding penicillin in animal feed to show its safety
under 512(e)(1)(B) of FDCA. 113
Twenty-one drug firms, organizations, and individuals requested
hearings to prove relevant uses were safe, but the hearings were
never scheduled. 114 Both the FDA and CDC issued guidance and
information related to the overuse of antibiotics. The guidance
indicated that when antibiotics are overused, their efficacy becomes
diminished when used in legitimate medically necessary situations.
In December 2011, FDA rescinded the 1977 notice of opportunity
for hearings. 115
However, due to agency capture,'

6

even the 2012 court order'

17

to

immediately initiate withdrawal proceedings failed to cause FDA to
close the loophole on the routine use of antibiotics on factory farms.
2. FDA Guidance for Industry 209 & 213 Aimed to Increase
Judicious Use of Antibiotics in Food-Producing Animals
The FDA has taken action as a result of being ordered to withdraw
approval of antibiotics used sub-therapeutically in livestock. First, it
issued Guidance for Industry #209 ("GFI 209") entitled, "Judicious
Use of Antimicrobials." 118 The second, and more powerful,
Guidance for Industry #213 ("GFI 213") was published on December
11, 2013.1 9 It is called, "New Animal Drugs and New Animal Drug
Combination Products Administered in or on Medicated Feed or
Drinking Water of Food-Producing Animals: recommendations for
112. Antibiotics and Sulfonamide Drugs in the Feed of Animals, 21 C.F.R. §
135.109 (2014).
113. Penicillin-Containing Premixes, 42 Fed. Reg. 43,772, 43,792 (Aug. 30,

1977).
114. See Nat. Res. Def. Council, Inc. v. U.S. Food & Drug Admin., 884 F. Supp.
2d 127, 131 (S.D.N.Y. 2012).

115. Withdrawal of Notices of Opportunity for a Hearing; Penicillin and
Tetracycline Used in Animal Feed, 76 Fed. Reg. 79697, 79697 (Dec. 22, 2011).
116. See Brian Daluiso, "Is the Meat Here Safe?" How Strict Liability for
Retailers Can Lead to Safer Meat, 92 B.U. L. REV. 1081, 1097-98 (May 2012).
117. Nat. Res. Def Council,Inc., 884 F. Supp. 2d at 151.
118. GFI #209.
119. GFI#213.
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Drug Sponsors for Voluntarily Aligning Product Use Conditions with
GFI #209."
GFI 209 laid out what judicious use of antibiotics is, and what
types of uses are not deemed "judicious."
The focus of this document is on the use of medically
important antimicrobial drugs in food-producing animals.
Based on a consideration of the available scientific
information, FDA is providing a framework for the
voluntary adoption of practices to ensure the appropriate or
judicious use of medically important antimicrobial drugs in
food-producing animals. This framework includes the
principles of phasing in such measures as 1) limiting
medically important antimicrobial drugs to uses in foodproducing animals that are considered necessary for
assuring animal health; and 2) limiting such drugs to uses
in food-producing
animals that include veterinary oversight
120
or consultation.
GFI 213 explained that drug sponsors could voluntarily withdraw
uses for growth promotion and feed optimization in the next three
years. If drug sponsors fail to withdraw uses, the FDA would be
compelled to develop a new approach to reduce the use of antibiotics
on factory farms. Here is the 213's introduction:
This guidance is intended for sponsors of approved
applications for new animal drugs and new animal drug
combination products containing medically important
antimicrobial new animal drugs for use in or on medicated
feed or water of food-producing animals. The guidance
contains information for sponsors of such new animal
drugs and combination products to facilitate voluntary
changes to the conditions of use for such new animal drugs
and combination products consistent with FDA's
recommendations included in the guidance document
entitled "The Judicious Use of Medically Important
Antimicrobial Drugs in Food-Producing Animals"
120. GFI #209.
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(Judicious Use Guidance, GFI #209). In particular, the
purpose of this guidance is to provide sponsors with
specific recommendations on how to supplement their
approved new animal drug applications to align with
FDA's GFI #209.121
GFI 213 targets medically important antimicrobials used in the
feed and water of food-producing animals. The guidance's purpose
is to encourage drug sponsors to align use conditions with GFI 209
and to phase out the use of antimicrobials merely for production
purposes (e.g., growth promotion and feed efficiency). 122 GFI 209
provided two recommended principles on the appropriate or judicious
use of medically important antimicrobial drugs: limiting
antimicrobials to uses 1) necessary to assuring animal health, and that
2) includes veterinary oversight or consultation. The FDA considers
prevention of specific diseases to be a valid therapeutic use.123
While some might see GFI 209 and 213 as triumphant steps in the
right direction, others could view the guidelines as a complete failure
to close the loophole of antibiotics routinely administered in a
preventative fashion.

II. CONFLICT: FDA GFI 209 AND 213
STRENGTHS AND WEAKNESSES

Forty years of agency intransigence have finally given way to
guidance for industry related to judicious use of antibiotics and
voluntary withdraw of antibiotic use for growth promotion. The
guidance has caused supporters and critics to raise a myriad of
questions that can only be answered with time. Many public health
experts and industry journalists believe the guidance is just a media
distraction while the FDA helps drug
companies re-label antibiotics
12 4
uses.
medical
other
under
to qualify

121. GFI #213.
122. Id.
123. GFI #209.
124. See e.g., Beth Hoffman, New FDA 'Rules' Not Likely to Reduce Antibiotic
Use on Farm, FORBES,
Dec. 13, 2013, http://www.forbes.com/sites/
bethhoffman/2013/12/13/new-fda-rules-will-not-reduce-antibiotic-use-on-farm/.
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The FDA's nonbinding recommendation that drug sponsors
voluntarily align their product use conditions with judicious use
guidelines is insufficient to achieve the kind of results for which
world health organizations, scientific associations, shareholders, and
citizens have long advocated. The FDA is charged with protecting
public health. Antibiotic resistance has been a major health issue for
decades. When there is a court order mandating FDA to take action
on antibiotic use, the agency's guidance should not be voluntary. If
the FDA is really aiming for judicious use, then the restrictions on
antibiotics use for non-medical purposes should be clear and firm.
But the actual impact of the guidelines seems insignificant.
According to industry insiders and pharma companies, antibiotics
used for growth promotion represents such a small share of all
antibiotics used in livestock, there will not be a substantial impact on
their sales revenues. 125
A. FDA Guidance is a Meaningful Step Toward Reducing
Antibiotic Usage and Antibiotic-ResistantBacteria
The FDA believes it is taking a meaningful step toward
encouraging judicious use of antibiotics in livestock. As GFI 213
was published, the FDA news release 126 heralded the guidance by
characterizing it in the following way, "Agency implementing plan to
ensure judicious use of antibiotics in food animals." 127 Bernadette
Dunham, DVM, Ph.D., director of the FDA's Center for Veterinary
Medicine, explained that the GFI "promotes the judicious use of
important antimicrobials to protect public health while ensuring that
sick and at-risk animals receive the therapy they need. 1 28
1. Drug Sponsor and Industry Compliance
The FDA has reason to believe their guidance will yield results.
The Administration has previously successfully withdrawn approval

125. Id.
126. See FDA Takes Significant Steps to Address Antimicrobial Resistance, U.S.
FoOD & DRUG ADMIN. (Dec. 11, 2013), http://www.fda.gov/NewsEvents/

Newsroom/PressAnnouncements/ucm378193.htm.
127. Id.
128. Id.
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for antibiotics. GFI 213 comes at the heels of the 2005 FDA decision
to withdraw of approval for livestock antibiotic, Baytril®.129 Drug
sponsor Bayer did not fight the decision. This could be indication
that other drug sponsors might react similarly.
Further, industry groups have reacted with vigor. Iowa Pork
Producer Headlines ("The Headlines"), a publication of the Iowa
Pork Producers Association, reviewed GFI 209, 13 and acknowledged
that although GFI 209 is only guidance and not law, it indicates the
FDA's future plans and will be adhered to as though it were
mandatory. 131 If the Association is indicating it will follow the
guidance, it will probably influence pork producers to follow
guidelines or begin implementing processes and procedures that
would anticipate formal rules or regulations around antibiotic use.
The Headlines presented economic predictions warning farmers
that the new FDA guidance could potentially increase the cost of
raising a pig in its first year by as much as $4.50. 13 2 As most
businesses are profit-driven, cost-production increases are typically
dreaded. Farmers might read this economic prediction of increased
costs and begin to think about how they can maintain current costs.
The Headlines also provides practical recommendations such as
keeping buildings clean, treating sick pigs with medicine, and
changing antibiotics to non-medically important ones. 133 These
recommendations appear to be in line with good animal husbandry
practices and hopefully are simply re-emphasizing existing practices.
The FDA also has open support from groups who advocate for
decreased antibiotic use. The Alliance for the Prudent Use of

129. See Vanessa K.S. Bricefio, Recent Developments, Superbug Me: The FDA's

Role in the Fight Against Antibiotic Resistance, 9 N.Y.U. J. LEGIS. & PUB. POL'Y
521, 521-522 (2005-2006).
130. See IOWA PORK PRODUCERS Ass'N, The Future of Antibiotics - A Review
of FDA Guidance 209, 11 HEADLINES NEWSLETTER, no. 1, 2012, available at
http://iowapork.org/FileLibrary/States/IANews/Headlines /o20Newsletter/Headline
s%20Summer%2012.pdf.

131. Id. at2.
132. Id. at 3.
133. Id.

2015]

FORDHAM ENVIRONMENTAL LA W RE VIE W

Antibiotics ("APUA") calls it a step in the right 13direction
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2. Stakeholder Buy-In
Another factor that makes the guidance likely to succeed is that the
FDA consulted with affected parties, drug companies, veterinarians
and relevant stakeholders to obtain buy-in before putting forth GFI
209 and 213. 135 There is a generous, three-year timeline for
voluntary changes, so sponsors will have ample opportunity to make
changes. Now that a few months have passed since GFI 213 was
announced, we can see the buy-in was productive. Nearly all drug
companies who make antibiotics used in animal feed agree to go
along with the guidance. 136 They will voluntarily withdraw the claim
from labels in accordance with agency nonbinding recommendations.
Skeptical public health experts point out the13 7industry could continue
to use antibiotics, but under other pretenses.
B. The Guidance will be Largely Ineffective Due to the Mode and
Language used by the FDA
1. The FDA's Use of Guidelines Instead of
Rulemaking or Mandatory Claims Withdrawal Reduces the
Probability the Agency will Achieve the Desired Result
Claim switching threatens the effectiveness of industry guidance.
When a drug sponsor loses the ability to sell a product with one claim
on the label, it switches to a different approved claim to maintain
market share.
The FDA press release focuses on private party interests. 138 It
looks to possible harms to the pharmaceutical industry or
134. FDA Releases Two Guidelines to Limit Use of Antibiotics in Meat
Production, ALLIANCE
FOR
THE
PRUDENT
USE
OF
ANTIBIOTICS,
http://www.tufts.edu/med/apua/policy/policyantibiotic-food-animals.shtml.
135. GFI#209.
136. See Sabrina Tavernise, F.D.A. Unveils Deal to Limit Antibiotic Use in
Animal Feed,N.Y. TIMES, Mar. 27, 2014, at B2.
137. See id.
138. FDA Takes Significant Steps to Address Antimicrobial Resistance, U.S.
FOOD & DRUG ADMIN. (Dec. 11, 2013), http://www.fda.gov/NewsEvents/

Newsroom/PressAnnouncements/ucm378193.htm.
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agribusiness. It is not focused on the positive health effects or
benefits to public health. The FDA's GFI 213 press announcement
described the guidance as a "road map for animal pharmaceutical
companies to voluntarily revise the FDA-approved use conditions on
139
the labels of these products to remove production indications."
Ms. Dunham, Director of CVM, also said, "We realize that these
steps represent changes for veterinarians and animal producers, and
we have been working - and will14continue
to work - to make this
0
transition as seamless as possible."
The guidance targets a narrow category of use. Growth promotion
is not believed to account for the bulk of sub-therapeutic use on
modern farms. Although it is difficult to obtain information about
actual usage, some believe only 10-15 percent of antibiotics used in
livestock is for growth promotion. 14 1 If growth promotion is not
currently a significant use and drug companies do not anticipate the
guidance to affect sales, is the guidance merely lip service?142
The mode of "industry guidance" is not a solution for a serious
problem that requires radical change. The way the guidance is
written, it hardly seems like a recommendation. On the top of every
page are the words "Contains Nonbinding Recommendations." The
document makes clear that guidance represents the agency's current
position and is nonbinding. At the Introduction, the guidance
reminds the reader it describes the FDA's current thinking, and use of
the word "should" is a suggestion, not a requirement. The guidance
also makes it clear that should a company decide to disregard the
agency's position entirely, there will be no repercussions. It raises
143
suspicion that drug companies are largely on board with guidance,
that, if taken on its face, would radically change industrial farming.

139. Id.
140. Id.
141. Beth Hoffman, New Animal 'Rules'NotLikely to Reduce Antibiotic Use on

Farm, FORBES, Dec. 13, 2013, http://www.forbes.com/sites/bethhoffman/
2013/12/13/new-fda-rules-will-not-reduce-antibiotic-use-on-farm.
142. Id.
143. Rebecca Thistlethwaite, Subterfuge: FDA's Phase Out of Antibiotics for
Animal Growth Purposes Ineffective - Will Disadvantage Small Farmers, THE
CORNUCOPIA

INSTITUTE,

Jan. 31,

2014, http://www.cornucopia.org/2014/02/

subterfuge-fdas-phase-antibiotics-animal-growth-purposes-ineffective-will-

disadvantage-small-farmers-2/a.
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Industry insiders fail to hide their true intentions or beliefs about
what the guidance will mean on the farm. We peer behind the veil on
the American Association of Swine Veterinarians' ("AASV")
website where Henry Snelson, DVM, AASV Director of
Communications assures the industry that the FDA has indicated they
will work with drug sponsors to add medically valid indications to
claim labels. 144 So as drug companies voluntarily withdraw one
claim from a label, another claim will be approved so the drug may
still be administered within new guidelines.
2. Failure to Define Words Like Sub-Therapeutic or
Explain When Preventative Uses are Allowed will Result in
Continued Usage Under Different Auspices
Conducting a textual analysis of the guidance for industry reveals
the language, word choice, and phrasing is vague. PEW Campaign
on Human Health and Industrial Farming Project Director, Laura
Rogers penned an eloquent letter to the FDA during the comment
period for Guidance 209.145 Ms. Rogers applauds the FDA for
openly acknowledging the dangers associated with antibiotics used
for growth promoting purposes. 146 She goes on to point out that the
guidelines fail to define several key phrases, namely disease
prevention and legitimate therapeutic use. Working with loosely
defined terms, drug companies may be able to alter labels of existing
pharmaceuticals resulting in little actual change in usage. 147 PEW
pushes further, contending that disease prevention is also an
inappropriate use. 148 This harkens back to the first regulatory

144. Harry Snelson, Advocacy in Action; Guidance #209 and you, AMERICAN

http://www.aasv.org/shap/issues/v20n4/
v20n4advocacy.html.
145. Joshua Wenderoff, Pew Asks FDA to Strengthen Guidelines on Antibiotic
Use in Food Animals, PEW CHARITABLE TRUSTS (July 20, 2012),
http://www.pewhealth.org/reports-analysis/issue-briefs/pew-asks-fda-to-strengthenguidelines-on-antibiotic-use-in-food-animals-85899406584.
ASSOCIATION OF SWINE VETERINARIANS,

146. Id.
147. Id.
148. Id.
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rollbacks of the 1950's when disease prevention was first allowed as
a use.

149

Recent FDA inaction on the issue of sub-therapeutic use of
antibiotics is a clear illustration of what is known as "agency
capture." For the FDA to effectively regulate animal drugs, it must
act independently. 150 Agency capture is often achieved through
lobbying and results in the agency serving private interests instead of
the public good. 151 When discussing the transition from OTC to
Veterinary Feed Directive status, the FDA is concerned with the
impact on veterinarians, the animal feed industry, and animal
producers, i.e. private interests. It does not focus on public good.
Now that a few months have passed since GFI 213 was announced,
nearly all drug companies who make antibiotics used in animal feed
have indicated they intend to comply with the guidance. 152 Almost
surprisingly, they voluntarily withdrew production claims from labels
in accordance with agency nonbinding recommendations. Public
health experts point out that the industry could continue to use
antibiotics, but under new therapeutic pretenses. 153
Some students of this area of regulation doubt readiness to separate
food from drugs. 154 The way GFI 213 is worded, antibiotics are
banned from use as growth promoters, but they may be used to
prevent disease. 155 Using antibiotics to prevent disease has been
named the "preventative use" loophole. The "preventative use"
loophole 156 explains why pharmaceutical executives feel secure
enough to make statements on record reassuring shareholders that the
new FDA guidance will not affect their pharmaceutical company's

149. Certification of Batches of Antibiotic-Containing Drugs, 16 Fed. Reg. 3647,
3648 (Apr. 28, 1951).
150. Daluiso, supra note 116.
151. Id.

152. Tavernise, supra note 136.
153. Id.
154. Marguax Birdsall, Biopharming, Bananas and Bureaucracy: The Banana
Vaccine as a Case Study for Products that Straddle the Food/Drug Divide, 66
FOOD DRUG L.J. 265, 282 (2011).

155. GFI #213.
156. Ben Elgin & Andrew Martin, FDA Crackdown on Antibiotics Relies on
Unproven Steps, BLOOMBERG, Jan. 2, 2014, http://www.bloomberg.com/news/
2014-01-03/fda-crackdown-on-antibiotics-relies-on-unproven-steps.html.
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bottom line. 157 The leading animal antibiotic manufacturer, Zoetis
CEO Juan Alaix, said the guidance would not have a significant
impact on their revenues and little effect on the usage of antibiotics in
livestock. 158 A spokesman for Eli Lilly's animal health division,
Elanco, said the new industry guidelines will not have a material or
significant impact. 159
The FDA provides three years to implement changes. Because this
is industry guidance and not a rule and it does not create or confer
any rights to anyone, it is unclear what will happen at the end of three
years. Will there be any action if sponsors who submitted notice to
voluntarily withdraw fail to do so?
3. FDA has Assured Drug Companies It will Work with Them to
Re-label Antibiotics Under Medically Acceptable Uses
The FDA promises to coordinate with drug sponsors to help them
implement changes. 160 If a drug had previously been used for
production purposes but also has a therapeutic benefits supported by
scientific evidence, sponsors can seek new therapeutic indications.
Drug sponsors are encouraged to voluntarily revise conditions to
reflect the need for veterinary oversight.
The timeline for
implementation is quite generous. Drug sponsors are to notify the
FDA within three months of intentions to modify their products. The
FDA believes sponsors should be able to make changes within three
161
years.
Thomas G. Slama, MD, President of the Infectious Diseases
Society of America ("IDSA"), also submitted a letter during the
comment period for GFI 209.162 The tone is stem. IDSA rests on
157. Thistlethwaite, supra note 143.
158. Id.

159. Elgin & Martin, supra note 156.
160. GFI #213.
161. Id.
162. See Thomas G. Slama, Comments on FDA Animal Antibiotic Use
Documents, INFECTIOUS DISEASES SOCIETY OF AMERICA (July 11, 2012), available
at http://www.idsociety.org/uploadedFiles/IDSA/Policyand Advocacy/Current
TopicsandIssues/AntimicrobialResistance/Agriculture/Letters/Test/IDSA%20C
omments%20on%20FDA

11 12.pdf.
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scientific evidence commanding a radical change in the way
antibiotics are used - bidding us enter a post-antibiotic era. 163 IDSA
also brings up the worry that drug makers will simply re-label the
same antibiotics and sell them under different uses. He reminds the
FDA of the ultimate goal of significantly decreasing overall
164
antimicrobial use in food animals.
III. RECOMMENDATIONS:
FDA SHOULD CLOSE THE LOOPHOLES NOW WITH
RULES, SURVEILLANCE, AND PENALTIES

While some believe FDA GFI 213 is a step towards reducing
antibiotic overuse in livestock, this note will explain it is completely
inadequate. Unregulated antibiotic use on the modem farm is
resulting in multi-drug resistant bacteria. A false image of security is
more dangerous than an enemy in the open.
There are four agencies involved in ensuring the safety of the food
that reaches your dinner table. Over the past forty years, civil,
legislative, and judicial actions based on scientific evidence
demanded a change in the way antibiotics are routinely used in
agribusiness. Neither the regulating agencies nor the other actions
have been able to tackle antibiotic overuse in food-producing
animals.
From 1977 to 2011, the FDA left a NOOH open and declined to
investigate the safety of antibiotics. Recently, the FDA published
GFI 213, which tells drug companies they may voluntarily align use
claims to be more judicious. There is little belief that a voluntary,
nonbinding mechanism would be an effective means to create
meaningful change in either the agricultural or pharmaceutical
industries. On the contrary, beef lobbyists have petitioned for fewer
checkpoints between their beef and the dinner table. 165

163. See id.
164. See id.
165. ELANOR STARMER, THE AGRIBUSINESS ACCOUNTABILITY INITIATIVE,
HOGGING THE MARKET: How POWERFUL MEAT PACKERS ARE CHANGING OUR
SYSTEM
AND
WHAT
WE
CAN
DO
ABOUT
IT,
available at
http://www.ase.tufts.edu/gdae/Pubs/rp/AAI Issue Brief 4.pdf
(explaining there
are no meat processing facilities in Wyoming that require federal inspection).
FOOD
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Pharmaceutical companies are notorious for finding loopholes in
each step from safety and effectiveness to false claims to marketing.
FDA guidance is an insufficient measure to reduce use of
antibiotics used in food-producing animals.
The mode of
recommendation - Guidance for Industry - is not designed to create
change. The language is undefined and creates loopholes. Agency
capture means that the 16
FDA
is erroneously focused on the industry
6
health.
public
of
instead
The FDA has failed to close address routine prevention uses.167
Pew and Consumer Reports recommendations posit we could patch
the many food safety issues around antibiotic resistance bacteria
found on meat by reducing overuse of farm antibiotics, declaring
Salmonella an adulterant, revising the data standards for the
organism, and
giving FSIS authority to enforce U.S. food safety
16 8
regulations.
To close these loopholes and create a regulatory environment
where antibiotics are used for their originally intended purpose of
treating diseased animals, Congress should pass H.R. 1150:
Preservation of Antibiotics for Medical Treatment Act of 2013
("PAMTA") 169 and stop OTC use of antibiotics for sub-therapeutic
use immediately. PAMTA is aimed at ending the routine use of
antibiotics on healthy livestock and reducing the threat of
superbugs. 170 The FDA should require prescriptions for antibiotics
only for therapeutic uses. This means redefining therapeutic to
narrowly capture only medically necessary uses and exclude broadbrush preventative use. The industry understanding of "prevention"
would no longer be a qualified therapeutic use. Also, herd-wide
prescriptions would be permitted only in exceptional circumstances.
Should drug companies use false claims, veterinarians prescribe off
label, or farm owners misrepresent disease, the FDA would be able to
pursue criminal charges and fines.
After initial rules have been established, the government can look
to take secondary steps to ensure a successful follow through.
166.
167.
168.
169.
1150,
170.

Daluiso, supra note 116.
See Elgin & Martin, supra note 156.
See McKenna, supra note 65.
See Preservation of Antibiotics for Medical Treatment Act of 2013, H.R.
113th Cong. (2013).
See id.
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Surveillance of the regulations through industry reporting would
provide information necessary for enforcement. Civil or criminal
action and accompanying penalties would reinforce the importance of
adhering to guidelines.
For example, veterinarians would report prescriptions and
pharmaceutical companies will report sales figures to FDA. The
USDA could classify strains of bacteria like salmonella that are
resistant to multiple antibiotics and known to have caused disease as
"adulterants" so tainted meat couldn't be brought to market. FSIS
would be empowered to monitor compliance with regulatory
requirements through existing product control actions. The burden
should be shifted back to processors in a strict-liability fashion to
encourage the appropriate level of attention.
Although the FDA's recent guidance might not be the change
public health advocates are looking for, its failure might provide a
backdrop for more effective steps.
IV.

CONCLUSION

To address antibiotic overuse and prevent the emergence of a
Superbug, the United States should take the following immediate
steps. Congress should pass the Preservation of Antibiotics for
Medical Treatment Act to stop OTC use of antibiotics for subtherapeutic use. The FDA should only permit prescriptions for
antibiotics for therapeutic uses. Herd-wide prescriptions would be
permitted only in exceptional circumstances. Should drug companies
use false claims, veterinarians prescribe off label, or farm owners
misrepresent disease, the FDA would be able to pursue criminal
charges and fines. It is the farmer's responsibility to raise livestock
in a healthy environment without antibiotic overuse. We ought to
shift the burden of regulatory compliance back to food processors in
a strict-liability fashion.
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